ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Upregulation of SKA3 enhances cell proliferation and correlates with poor prognosis in hepatocellular carcinoma

Tang, Jianxin; Liu, Jing; Li, Jinjun; Liang, Ziming; Zeng, Kaining; Li, Haibo; Zhao, Zhenlin; Zhou, Li*; Jiang, Nan*广东药学院; 南方医科大学; 中山大学; 1
Oncology Reports2021-4DOI: 10.3892/or.2021.7999
5被引4阅读
引用收藏
分享

摘要

Hepatocellular carcinoma (HCC) is one of the most aggressive types of malignancy worldwide. However, the mechanism underlying its frequent recurrence remains unclear. Studies have demonstrated that spindle and kinetochore associated complex subunit 3 (SKA3) is highly expressed in colorectal and prostate cancer. The present study aimed to determine whether SKA3 could be a predictive and prognostic marker for liver cancer. SKA3 expression levels in liver cancer cell lines, liver cancer tissues, normal liver cells and non-cancerous tissues were compared at both transcriptional and translational levels. Correlation between SKA3 levels, clinicopathological characteristics and patient survival was also assessed. Gene set enrichment analysis (GSEA) was performed to identify SKA3-associated pathways. Furthermore, SKA3 was knocked down and overexpressed in liver cancer cells, and then assessed the effect on cell proliferation, cell cycle, and tumor formation ability. Kaplan-Meier survival analysis and log-rank test were used to evaluate the association between SKA3 expression levels and prognosis. SKA3 mRNA and protein expression levels were significantly higher in liver cancer cell lines and clinical samples, compared with normal controls. Immunohistochemical analysis of 110 patients revealed that upregulation of SKA3 correlated with clinical pathological characteristics and patient survival. GSEA showed that BENPORATH_PROLIFERATION gene set signaling pathways were correlated with SKA3 expression levels. Luciferase reporter activity assay revealed that knockdown of SKA3 significantly inhibited the activity of transcription factor E2F. Downregulation of SKA3 significantly inhibited cell proliferation, cell cycle arrest in G(1)-S phase and tumorigenesis both in vitro and in vivo, decreased the expression levels of cyclin D1 and phosphorylated-retinoblastoma and increased those of p21, suggesting a potential role of SKA3 in mediating tumor cell cycle and progression. SKA3 may function as an oncogene in liver cancer and may be a promising prognostic biomarker and candidate for targeted therapy.

学科与关键词

关键词
spindle and kinetochore associated complex subunit 3hepatocellular carcinomacell proliferationprognosis
相关
加载中…
  • Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma
    Xu, Weikang; Lu, Xinyu; Liu, Jing; Chen, Qianhui; Huang, Xuan; Huang, Kuiyuan; Liu, Hongyan*; Zhu, Wei*; Zhang, Xiaoyong*Frontiers in Oncology, 2021, 11.被引 4
  • Cleavage and polyadenylation-specific factor 3 induces cell cycle arrest via PI3K/Akt/GSK-3β signaling pathways and predicts a negative prognosis in hepatocellular carcinoma
    Li, Ning; Jiang, Shaotao; Fu, Rongdang; Lv, Jin; Yao, Jiyou; Mai, Jialuo; Hua, Xuefeng; Chen, Huan; Liu, Jie; Lu, Minqiang*Biomarkers in Medicine, 2021, 15(5): 347-358.被引 5
  • SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma
    Zhang, Baozhu*; Zhou, Qing; Xie, Qiankun; Lin, Xiaohui; Miao, Wenqiang; Wei, Zhaoguang; Zheng, Tingting; Pang, Zuoliang; Liu, Haosheng; Chen, Xi*Aging-US, 2021, 13(2): 2803-2821.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Oncology Reports
发表日期
2021-04
卷期
第 45 卷, 第 4 期
页码
48
DOI
10.3892/or.2021.7999
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81871999, 81572368]; Guangdong Natural Science Foundation [2016A030313278]; Science and Technology Planning Project of Guangdong Province, China [2014A020212084]; Shenzhen Key Medical Discipline Construction Fund [SZXK079]

作者

  • T

    Tang, Jianxin (第一作者)

    southern med univ · 2

  • L

    Liu, Jing

    sun yat sen univ

查看全部 9 位作者收起作者
  • L

    Li, Jinjun

    2

  • L

    Liang, Ziming

    sun yat sen univ

  • Z

    Zeng, Kaining

    sun yat sen univ

  • L

    Li, Haibo

    sun yat sen univ

  • Z

    Zhao, Zhenlin

  • Z

    Zhou, Li (通讯)

    1 · guangdong pharmaceut univ

  • J

    Jiang, Nan (通讯)

    2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417